PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31125123-4	2020	VPS33B overexpression suppressed CRC proliferation, intrahepatic metastasis and chemoresistance of cisplatin (DDP) in vivo and in vitro through modulating the epidermal growth factor receptor (EGFR)/RAS/ERK/c-Myc/p53/miR-133a-3p feedback loop and the downstream cell cycle or EMT-related factors.	Cisplatin	99-108	VPS33B late endosome and lysosome associated	Homo sapiens	0-6	
31125123-4	2020	VPS33B overexpression suppressed CRC proliferation, intrahepatic metastasis and chemoresistance of cisplatin (DDP) in vivo and in vitro through modulating the epidermal growth factor receptor (EGFR)/RAS/ERK/c-Myc/p53/miR-133a-3p feedback loop and the downstream cell cycle or EMT-related factors.	Cisplatin	110-113	VPS33B late endosome and lysosome associated	Homo sapiens	0-6	
33997178-0	2021	VPS33B suppresses lung adenocarcinoma metastasis and chemoresistance to cisplatin.	Cisplatin	72-81	VPS33B late endosome and lysosome associated	Homo sapiens	0-6	
33997178-3	2021	Overexpressed VPS33B was shown to reduce the migration, invasion, metastasis, and chemoresistance of LUAD cells to cisplatin (DDP) in vivo and in vitro.	Cisplatin	115-124	VPS33B late endosome and lysosome associated	Homo sapiens	14-20	
33997178-3	2021	Overexpressed VPS33B was shown to reduce the migration, invasion, metastasis, and chemoresistance of LUAD cells to cisplatin (DDP) in vivo and in vitro.	Cisplatin	126-129	VPS33B late endosome and lysosome associated	Homo sapiens	14-20